PAPER Fraldi A, Serafini M, Sorrentino NC, Gentner B, Aiuti A, Bernardo ME
SEARCH RESULTS
4078 RESULTS
PAPER Naphade S, Tshilenge KT, Ellerby LM
Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.
Neurotherapeutics. 2019 Oct;16(4):979-998. PubMed: 31792895PAPER Rezak M, de Carvalho M
Disease modification in neurodegenerative diseases: Not quite there yet.
Neurology. 2020 Jan 7;94(1):12-13. Epub 2019 Dec 2 PubMed: 31792097PAPER Ford E, Rooney P, Oliver S, Hoile R, Hurley P, Banerjee S, van Marwijk H, Cassell J
Identifying undetected dementia in UK primary care patients: a retrospective case-control study comparing machine-learning and standard epidemiological approaches.
BMC Med Inform Decis Mak. 2019 Dec 2;19(1):248. PubMed: 31791325PAPER Xie W, Gao J, Jiang R, Liu X, Lai F, Tang Y, Xiao H, Jia Y, Bai Q
Twice subacute MPTP administrations induced time-dependent dopaminergic neurodegeneration and inflammation in midbrain and ileum, as well as gut microbiota disorders in PD mice.
Neurotoxicology. 2020 Jan;76:200-212. Epub 2019 Nov 29 PubMed: 31790727PAPER Coupland CA, Moore M, Hippisley-Cox J
Association of Anticholinergic Drug Exposure With Increased Occurrence of Dementia-Reply.
JAMA Intern Med. 2019 Dec 1;179(12):1730-1731. PubMed: 31790531PAPER Farkas RH, Miller LG
Association of Anticholinergic Drug Exposure With Increased Occurrence of Dementia.
JAMA Intern Med. 2019 Dec 1;179(12):1729-1730. PubMed: 31790522PAPER Paul LM
Association of Anticholinergic Drug Exposure With Increased Occurrence of Dementia.
JAMA Intern Med. 2019 Dec 1;179(12):1729. PubMed: 31790521PAPER Comella Bolla A, Valente T, Miguez A, Brito V, Gines S, Solà C, Straccia M, Canals JM
CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease.
PLoS One. 2019;14(12):e0224901. Epub 2019 Dec 2 PubMed: 31790427PAPER Husain M
Targeting network dysfunction in neurodegenerative diseases.
Brain. 2019 Dec 1;142(12):3661-3662. PubMed: 31789369PAPER Sergi D, Renaud J, Simola N, Martinoli MG
Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences.
Front Aging Neurosci. 2019;11:302. Epub 2019 Nov 8 PubMed: 31787891PAPER Oliveira-Giacomelli Á, M Albino C, de Souza HD, Corrêa-Velloso J, de Jesus Santos AP, Baranova J, Ulrich H
P2Y6 and P2X7 Receptor Antagonism Exerts Neuroprotective/ Neuroregenerative Effects in an Animal Model of Parkinson's Disease.
Front Cell Neurosci. 2019;13:476. Epub 2019 Nov 8 PubMed: 31787881PAPER Hassan-Abdi R, Brenet A, Bennis M, Yanicostas C, Soussi-Yanicostas N
Neurons Expressing Pathological Tau Protein Trigger Dramatic Changes in Microglial Morphology and Dynamics.
Front Neurosci. 2019;13:1199. Epub 2019 Nov 7 PubMed: 31787873PAPER De Snoo ML, Friesen EL, Zhang YT, Earnshaw R, Dorval G, Kapadia M, O'Hara DM, Agapova V, Chau H, Pellerito O, Tang MY, Wang X, Schmitt-Ulms G, Durcan TM, Fon EA, Kalia LV, Kalia SK
Bcl-2-associated athanogene 5 (BAG5) regulates Parkin-dependent mitophagy and cell death.
Cell Death Dis. 2019 Dec 2;10(12):907. PubMed: 31787745PAPER Benussi A, Dell'Era V, Cantoni V, Cotelli MS, Cosseddu M, Spallazzi M, Micheli A, Turrone R, Alberici A, Borroni B
TMS for staging and predicting functional decline in frontotemporal dementia.
Brain Stimul. 2020 Mar - Apr;13(2):386-392. Epub 2019 Nov 22 PubMed: 31787557Current Filters
- Date Range : Sep 2019 to Dec 2019 x